Journal Article Summary

The article investigates the effectiveness of nystatin and liposomal nystatin against various clinical isolates of Candida, a type of yeast that can cause infections in humans. Understanding how these antifungal agents perform is crucial, especially as Candida infections can be serious and difficult to treat, particularly in immunocompromised patients. The study aims to provide insights into the minimum inhibitory concentrations (MICs) of these medications, which indicate the lowest amount needed to prevent yeast growth.

The researchers tested 103 Candida isolates using different growth media and incubation times to determine the MICs of nystatin, liposomal nystatin, amphotericin B, and fluconazole. They found that nystatin and liposomal nystatin generally showed good antifungal activity against all tested strains. Notably, while the MICs for nystatin were similar to or slightly lower than those for liposomal nystatin in some media, they were significantly higher in others. The study also revealed that liposomal nystatin might be effective against some strains resistant to amphotericin B, suggesting its potential as a treatment option.

However, the study has limitations, including the fact that it was conducted in vitro, meaning the results may not fully reflect how these medications would perform in actual patients. Additionally, the researchers noted that further testing in animal models is necessary to confirm their findings. Patients should discuss these results with their healthcare providers, especially if they are dealing with Candida infections, to understand the best treatment options available and any potential implications for their care.

Medical Safety Note

This journal article summary is provided for educational purposes only and is not medical advice. Always consult a licensed healthcare professional before starting, stopping, or changing any medication.

Article Cited

  1. Arikan Sevtap, Ostrosky-Zeichner Luis, Lozano-Chiu Mario, Paetznick Victor, Gordon David, Wallace Tom, Rex John H.. In Vitro Activity of Nystatin Compared with Those of Liposomal Nystatin, Amphotericin B, and Fluconazole against Clinical Candida Isolates. Journal of Clinical Microbiology 2002. DOI: 10.1128/JCM.40.4.1406-1412.2002. PMID: 11923365. PMCID: PMC140327.

Featured Pill Pals Product

Pill Pals® is THE Express Pharmacy. Our Nationwide Pharmacy Network was created with the mission of helping you make SENSE of your meds™. As a Pharmacy Benefits Management organization, Pill Pals® gives patients the best cash prices on all meds. Pill Pals® is part of The Health Pals® Company (Health Pals®, Med Pals®, Skin Pals® etc), a vertically integrated Healthcare System that provides cost effective Medical and Pharmacy services to Employers, Patients, and more. For more information, please email [email protected]